SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-009759
Filing Date
2019-01-15
Accepted
2019-01-15 16:08:04
Documents
3
Period of Report
2019-01-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d553006d8k.htm 8-K 15810
2 EX-99.1 d553006dex991.htm EX-99.1 7606
3 GRAPHIC g553006g55u03.jpg GRAPHIC 2059
  Complete submission text file 0001193125-19-009759.txt   27494
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 19527210
SIC: 2834 Pharmaceutical Preparations